SCHEMBL28592

SCHEMBL28592

O=[N+]([O-])c1ccccc1[S]

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.54
TDP1 Q9NUW8 5/20 0.52
ALDH1A1 P00352 8/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
GPR35 Q9HC97 1/20 0.50
TSHR P16473 3/20 0.48
NPC1 O15118 1/20 0.47
RECQL P46063 1/20 0.47
RAB9A P51151 1/20 0.47
MAPK1 P28482 1/20 0.45
CASP7 P55210 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
PLAU P00749 1/20 0.44
PTPRC P08575 1/20 0.44
S100A4 P26447 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluoride SCHEMBL984644 0.98 HSD17B10 (0.52) HSD17B10TDP1ALDH1A1KMT2AMEN1
Fluoride SCHEMBL944131 0.98 HSD17B10 (0.52) HSD17B10TDP1ALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL1851566 0.95 HSD17B10 (0.50) HSD17B10TDP1ALDH1A1KMT2AMEN1
SCHEMBL16355165 0.81 HSD17B10 (0.67) HSD17B10TDP1ALDH1A1KMT2AMEN1
SCHEMBL22566 0.81 HSD17B10 (0.67) HSD17B10TDP1ALDH1A1KMT2AMEN1
SCHEMBL29577518 0.81 HSD17B10 (0.67) HSD17B10TDP1ALDH1A1KMT2AMEN1
SCHEMBL9775860 0.79 TSHR (0.59) HSD17B10TDP1ALDH1A1KMT2AMEN1
Fluoride SCHEMBL11797732 0.78 HSD17B10 (0.64) HSD17B10TDP1ALDH1A1KMT2AMEN1
SCHEMBL6553157 0.78 HSD17B10 (0.64) HSD17B10TDP1ALDH1A1KMT2AMEN1
Hydrogen Sulfide SCHEMBL28883138 0.78 HSD17B10 (0.64) HSD17B10TDP1ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 8104 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4157834-B1 N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION MISSION THERAPEUTICS LTD (GB) 2024-07-03 EP claimed
US-20240199681-A1 OLIGONUCLEOTIDE AND NUCLEIC ACID SYNTHESIS EVONETIX LTD (GB) 2024-06-20 US claimed
WO-2024127026-A1 MEMBRANE FILTRATION-ASSISTED SOLUTION PHASE OLIGONUCLEOTIDE SYNTHESIS Exactmer Limited (GB) 2024-06-20 WO claimed
WO-2024081372-A1 PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN GILEAD SCIENCES, INC. (US) 2024-04-18 WO claimed
US-20230348453-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2023-11-02 US claimed
US-20230312580-A1 1-(5-(2-CYANOPYRIDIN-4-YL)OXAZOLE-2-CARBONYL)-4-METHYLHEXAHYDROPYRROLO[3,4-B]PYR ROLE-5(1H)-CARBONITRILE AS USP30 INHIBITOR FOR USE IN THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION, CANCER AND FIBROSIS MISSION THERAPEUTICS LIMITED (GB) 2023-10-05 US claimed
US-20230303547-A1 N-CYANOPYRROLIDINES WITH ACTIVITY AS USP30 INHIBITORS MISSION THERAPEUTICS LIMITED (GB) 2023-09-28 US claimed
US-11713340-B2 Divalent nucleobase compounds and uses therefor CARNEGIE MELLON UNIVERSITY (US) 2023-08-01 US claimed
US-20230234986-A1 INHIBITORS OF CORONAVIRUS PROTEASE SUNSHINE BIOPHARMA INC. 2023-07-27 US claimed
US-20230219939-A1 N-(1-CYANO-PYRROLIDIN-3-YL)-5-(3-(TRIFLUOROMETHYL)PHENYL)OXAZOLE-2-CARBOXAMIDE DERIVATIVES AND THE CORRESPONDING OXADIAZOLE DERIVATIVES AS USP30 INHIBITORS FOR THE TREATMENT OF MITOCHONDRIAL DYSFUNCTION MISSION THERAPEUTICS LIMITED (GB) 2023-07-13 US claimed
US-3997517-A PEPTIDE AMERICAN HOME PRODUCTS CORPORATION (US) 1976-12-14 US claimed
US-3993646-A Process for the ring expansion of penicillins to cephalosporin compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-11-23 US claimed
US-3980666-A Process for the resolution of D,L-penicillamine and salts formed during said process DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-09-14 US claimed
US-3980665-A Optically active salt of protected D-penicillamine and L-lysine DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-09-14 US claimed
US-3978063-A 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1976-08-31 US claimed
US-3965093-A 6-Arylthio penicillanic acid and derivatives thereof E. R. SQUIBB & SONS, INC. (US) 1976-06-22 US claimed
US-3954744-A ANTIBACTERIAL E. R. SQUIBB & SONS, INC. (US) 1976-05-04 US claimed
US-3954783-A Resolution process and salt of protected D-penicillamine and L-pseudonorephedrine DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-05-04 US claimed
US-RE28760-E Photographic element including superimposed silver halide layers of different speeds EASTMAN KODAK COMPANY (US) 1976-04-06 US claimed
US-3947464-A Salts of phenylpropanolamine with thiazolidine carboxylic acids DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) 1976-03-30 US claimed